
Chemical and Pharmaceutical Bulletin p. 829 - 841 (1995)
Update date:2022-09-26
Topics:
Kotake
Okauchi
Iijima
Yoshimatsu
Nomura
Structural modifications of an extremely potent inhibitor of dihydrofolate reductase (DHFR) activity and tumor cell growth, N-[4-[3-(2,4-diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidin-5-yl)propyl ]benzoyl]-L-glutamic acid (1), have led to the synthesis of
View MoreContact:+86-021-58123769
Address:No.780 of Cailun Road,Zhangjiang Hi-tech Park,Pudong,Shanghai
Contact:86-27-84888681
Address:Wuhan economic & technology development zone
Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd
Contact:0086-10-64430626
Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Tianjin Emulsion Science&Technology Development Co.,Ltd
Contact:13901380442
Address:Vake Garden New Town New Yi Bai Road Beichen District Tianjin,China
Jiangxi Lanqi Fine Chemical S&T Co., Ltd.
Contact:+86-21-64891143
Address:XinJiShan Industrial Area, Zhangshu City, JiangXi Province, China
Doi:10.1002/recl.19931120502
(1993)Doi:10.1038/nchem.1796
(2014)Doi:10.1002/ejoc.201300932
(2013)Doi:10.1039/c9ob01681c
(2019)Doi:10.1021/ol403083e
(2014)Doi:10.1021/ol403068j
(2014)